MedDataX Logo

RT-PCR Database Analysis for COVID-19 Infections and Re-infection

NCT ID: NCT04653844

Last Updated: 2022-01-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

7000000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-02-01

Study Completion Date

2023-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The SARS-Cov2 pandemic remains associated with many concerns. One of the them is the real frequency of likely re-infection and subsequently the level of protection conferred by the acquired immunity following primary-infection. We propose to analyze a large set of laboratory data produced since the early beginning of the SARS-Cov2 spread in the French population to identify recurrent infection events and, more generally, gain insight about infection kinetics.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prognostic Value of IgM in Covid-19 Infection

NCT05092594

COVID-19
UNKNOWN

Study of the Incidence of SARS-CoV-2 Infection (COVID-19)

NCT04429594

Coronavirus Infections
RECRUITING NA

Coagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 Infection

NCT04624997

COVID-19 SARS-CoV-2 Infection
UNKNOWN

Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection

NCT04863547

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
UNKNOWN

Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19

NCT04418206

Covid 19
COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid-19 SARS-CoV Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- People with at least one positive SARS-Cov2 RT-PCR result with a known sampling date

Exclusion Criteria

\- Patient refusing to participate in research
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Laboratoire CERBA-MPL

UNKNOWN

Sponsor Role collaborator

CNRS (MIVEGEC)

UNKNOWN

Sponsor Role collaborator

Nîmes University Hospital

UNKNOWN

Sponsor Role collaborator

University Hospital, Montpellier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vincent Foulongne, PhD

Role: STUDY_DIRECTOR

UH MONTPELLIER

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Uh Montpellier

Montpellier, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Samuel Alizon, PhD

Role: CONTACT

[email protected]
610654902 ext. 33

Vincent Foulongne, PhD

Role: CONTACT

[email protected]
467 330 254 ext. 33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Vincent Foulongne, PHD

Role: primary

[email protected]
467 330 254 ext. 33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RECHMPL20_0640

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

COVID-19 Prevalence in UNIVI Geriatric Institutions: Epidemiological Study of Immunological Status With Rapid Serological Tests
NCT04790994 UNKNOWN
Monitoring of the Post-vaccination Immune Response to COVID-19 Among Hospital Staff
NCT04896788 UNKNOWN NA
RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population
NCT04427358 COMPLETED
Prospective Clinical and Virological Analysis of Healthcare Workers Diagnosed Positive for Covid-19.
NCT04858581 UNKNOWN NA
Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection
NCT04750720 COMPLETED NA
COVID-19 Seroprevalence in Pregnant Women and Blood Donors
NCT04893057 COMPLETED
Detection of COVID-19 in Saliva Collection
NCT04386551 COMPLETED
Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID-19.
NCT04322279 TERMINATED
Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection
NCT04707820 COMPLETED NA
Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum Antibodies
NCT05315583 TERMINATED NA
CoViD-19 Patient in Reims University Hospital in March to April 2020
NCT04553575 COMPLETED
Evaluation of the Detection Performance of the N Antigenemia of SARS-CoV-2 in the General Population for the Diagnosis and Screening of COVID-19
NCT05092607 UNKNOWN NA
PCR Cycle Threshold Values and COVID-19 Outcomes
NCT04651413 COMPLETED
Study of Immune Response During SARS-CoV-2 Infection - (COVID-19)
NCT04355351 COMPLETED NA
Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution
NCT04664023 COMPLETED
Evaluation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen
NCT04707833 UNKNOWN NA
Investigating Immune Escape by SARS-CoV-2 Variants
NCT05171803 COMPLETED
Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine.
NCT04596098 COMPLETED
COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease
NCT04511949 COMPLETED NA
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
NCT04448145 RECRUITING
Effect of a Vaccination Against COVID-19 on Monocyte Production of Oxygenated Derivatives.
NCT05655351 COMPLETED EARLY_PHASE1
Co-Sér: Serological Analysis and Viral Neutralization in People With a Documented COVID-19 Infection
NCT05000307 COMPLETED NA
Rapid Molecular Diagnosis and Detection of Emerging Infectious Diseases in Patients With Tropical Fever (Tropifever)
NCT06539325 RECRUITING NA
Influence of the COVId-19 Pandemic on STRESS, and Screening Procedures (COVISTRESS Screening)
NCT04538586 RECRUITING
Variants of SARS-CoV-2 Causing COVID-19 in Africa
NCT05311891 UNKNOWN